מדינה: הממלכה המאוחדת
שפה: אנגלית
מקור: MHRA (Medicines & Healthcare Products Regulatory Agency)
Atenolol
Mawdsley-Brooks & Company Ltd
C07AB03
Atenolol
100mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 What Atenolol is and what it is used for. 2 What you need to know before you take Atenolol. 3 How to take Atenolol. 4 Possible side effects. 5 How to store Atenolol. 6 Contents of the pack and other information. WHAT ATENOLOL IS AND WHAT IT IS USED FOR 1 Atenolol belongs to a group of medicines called beta-blockers, which help your heart to beat more slowly and with less force, reducing blood pressure. Beta blockers also help blood vessels to open to improve blood flow. Atenolol is used to treat: • High blood pressure (hypertension) • Chest pain (angina pectoris) • Irregular heartbeat (cardiac dysrhythmias) • Protect the heart in the early treatment after a heart attack WHAT YOU NEED TO KNOW BEFORE YOU TAKE ATENOLOL 2 DO NOT TAKE ATENOLOL IF: • YOU HAVE A HISTORY OF WHEEZING OR ASTHMA. CONSULT YOUR DOCTOR OR PHARMACIST FIRST • You are allergic to Atenolol or any of the ingredients of this medicine (listed in section 6) • You suffer from heart problems such as: o Uncontrolled heart failure o 2 nd or 3 rd degree heart block o Weakened heart unable to pump blood around the body (cardiogenic shock) o A very slow heart rate (less than 45-50 beats per minute) [bradycardia] o Irregular heartbeat (sick sinus syndrome) • You have low blood pressure (hypotension) • You have very poor circulation • You have UNTREATED phaeochromocytoma (tumour of the adrenal gland) • You suffer from an increased level of acid in the blood (metabolic ac קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Atenolol 100mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Atenolol 100mg For excipients, see 6.1. 3 PHARMACEUTICAL FORM White, circular, biconvex, uncoated tablets with ‘FIL’ engraved above the score line, ‘100’ below the score line, on one side and plain on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Atenolol 100mg tablets are indicated for the management of: Hypertension Angina pectoris Cardiac arrhythmias Acute myocardial infarction, as early intervention. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults: _ _ _Hypertension: _ _ _ The majority of patients respond to a single oral dose of 100mg daily though some patients respond to 50mg, the effect being established fully after one or two weeks. A further reduction in blood pressure may be obtained by combining atenolol tablets with other antihypertensive therapy such as diuretics. _Angina: _ The majority of patients respond to a single oral dose of 100mg daily or to 50mg given twice daily. Increasing the dose above l00mg daily is unlikely to confer additional benefit. _Cardiac arrhythmias. _ _ _ The initial dose for control of arrhythmias by intravenous application of atenolol is 2.5mg. This dose may be administered in intervals of 5 minutes until the recommended effect is observed or until the maximum dose of 0.15mg per kg of body weight has been reached, respectively. When the arrhythmia has been controlled with intravenous atenolol, the recommended oral maintenance dose of Atenolol tablets is a single daily dose of 50 - 100mg. _ _ _Myocardial infarction: _ _ _ In those patients who are considered suitable for beta-blocker therapy (presenting for treatment within 12 hours of the onset of chest pain), appropriate intravenous beta-blocker therapy should be supplemented 15 minutes later by a single oral dose of 50mg atenolol tablet providing intravenous therapy has been well tolerated. A further oral dose of 50mg Atenolol tablet should be given 12 hours late קרא את המסמך השלם